About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 48 record(s)
Req # A-2022-00369
Briefing Note for the Minister of Innovation, Science and Industry: BN0011671 - Roadmap to Net-ZeroOrganization: Innovation, Science and Economic Development Canada
October 2022
Req # A-2022-00403
Briefing Note for the Minsiter of Innovation, Science and Industry: BN0012220 - Minister of Health and Minister of Innovation, Science and Innovation's Letter to [REDACTED]Organization: Innovation, Science and Economic Development Canada
September 2022
Req # A-2022-00291
Communications between ISED or the Competition Board and employees, agents or lobbyists for Bell or Telus pertaining to the transfer of spectrum for the period 15 March 2022 to 16 June 2022Organization: Innovation, Science and Economic Development Canada
August 2022
Req # A-2022-00071
Communications between retail stores and Maple Leaf Foods on a Competition Bureau price fixing investigationOrganization: Innovation, Science and Economic Development Canada
May 2022
Req # A-2021-001603
For the Abbreviated New Drug Submission underlying the generic submission under review containing the medicinal ingredient “trabectedin”, provide the cover letter from the drug sponsor.Organization: Health Canada
April 2022
Req # A-2021-00427
Briefing Note for the Minister of Innovation, Science and Industry: BN0008378: Briefing Calendar for Strategic Innovation Fund ProjectsOrganization: Innovation, Science and Economic Development Canada
March 2022
Req # A-2021-001600
For the Abbreviated New Drug Submission underlying the generic submission under review containing the medicinal ingredient “trabectedin”, provide the proposed Certified Product Information Document.Organization: Health Canada
February 2022
Req # A-2021-001601
For the Abbreviated New Drug Submission underlying the generic submission under review containing the medicinal ingredient “trabectedin”, provide the “Batch Formula” (3.2.P.3.2).Organization: Health Canada
February 2022
Req # A-2021-001602
For the Abbreviated New Drug Submission underlying the generic submission under review containing the medicinal ingredient “trabectedin”, provide the “Description of Manufacturing Process and Process Controls” (3.2.P.3.3).Organization: Health Canada
February 2022
Req # A-2021-001605
For the Abbreviated New Drug Submission underlying the generic submission under review containing the medicinal ingredient “trabectedin”, provide the proposed Product Monograph.Organization: Health Canada
February 2022